Medcare Diagnostics
Medcare Diagnostics is a Mumbai-based radiology and nuclear medicine imaging chain operating four owned centres and partnering with 50+ hospitals across western India, now majority-owned by MedGenome as part of an integrated imaging-and-genomics diagnostics platform.
- Company typePrivate
- Founded2012
- HeadquartersMumbai, India
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Medcare Diagnostics does
Medcare Diagnostics, founded in 2012 and headquartered in Mumbai, India, operates a regional network of radiology and nuclear medicine imaging centres serving western India. The company runs four owned integrated imaging centres across Chembur, Goregaon, Andheri, and Navi Mumbai, and maintains partnerships with over 50 hospitals across the region. Its service portfolio centres on advanced diagnostic modalities including PET-CT imaging, nuclear medicine scans, and other specialised imaging procedures, addressing demand for precision diagnostics in oncology, cardiology, and complex disease management.
The business operates a hybrid model combining direct-to-patient imaging at owned centres with referral-based imaging services delivered through partner hospitals. Its equipment base — particularly PET-CT scanners and nuclear medicine infrastructure — represents significant capital investment and requires radiation licensing and trained clinical specialists, both of which act as barriers for new entrants. With 51-100 employees, Medcare operates at the scale typical of regional specialty diagnostic chains in India. Pricing follows per-scan economics standard to the Indian diagnostic imaging market, with PET-CT and nuclear medicine commanding premium rates relative to standard modalities such as MRI or CT.
Following a March 2026 transaction, Medcare Diagnostics became a majority-owned subsidiary of MedGenome, embedding the imaging business within an integrated diagnostics platform that combines anatomical imaging with genomics-based testing. The combination is strategically relevant for oncology, where combined imaging and molecular diagnostics inform treatment selection. Integration details, transaction value, and post-deal operating metrics are not publicly disclosed.
Medcare Diagnostics firmographics
Firmographics- Name
- Medcare Diagnostics
- Legal name
- Medcare Diagnostics
- Website
- https://medcarediagnostics.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Medcare Diagnostics is a Mumbai-based radiology and nuclear medicine imaging chain operating four owned centres and partnering with 50+ hospitals across western India, now majority-owned by MedGenome as part of an integrated imaging-and-genomics diagnostics platform.
- Ownership category
- akta.pro rank
Medcare Diagnostics industry classification
Industry- Product category
- Diagnostic Imaging Services
- NAICS
- Diagnostic Imaging Centers (621512), Medical and Diagnostic Laboratories (62151), Offices of Physicians (except Mental Health Specialists) (621111)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
- akta.pro primary industry
- Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)
- akta.pro secondary industries
- Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI), Independent Diagnostic Testing Facilities (IDTFs) & Multi-Specialty Diagnostic Centers (HLAFAKAN)
Keywords
Where Medcare Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Mumbai
- HQ country
- India
- HQ region
- Asia
Offices5 records
Markets served
Medcare Diagnostics business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D
Distribution channels2 records
Medcare Diagnostics product offering
Product offeringCore offering
Medcare Diagnostics operates four integrated imaging centers across Mumbai (Chembur, Goregaon, Andheri, and Navi Mumbai) providing radiology, nuclear medicine, and PET-CT imaging services. Following MedGenome's majority investment, the offering is being extended into an integrated diagnostics ecosystem combining imaging with genomic and multi-omics testing for oncology and complex disease management.
Product overview
Medcare Management Services operates as a radiology and nuclear medicine provider with a network of four integrated imaging centers across Chembur, Goregaon, Andheri, and Navi Mumbai in Mumbai, India. Founded in 2012, the company offers advanced imaging services including PET-CT scans and nuclear medicine imaging, with over 50 hospital partnerships. Following MedGenome's majority investment, the services are being integrated with genomic testing capabilities to create a unified diagnostics ecosystem combining imaging, pathology, and genomics.
Differentiator
Problem solved
Functional benefit
Products and services
- PET-CT Imaging Services Positron emission tomography-computed tomography (PET-CT) scanning services providing advanced diagnostic imaging for oncology and complex disease management. Targets patients and referring physicians requiring precision diagnostic imaging across the Mumbai metropolitan region.
- Nuclear Medicine Imaging Advanced molecular imaging using nuclear medicine technology, supporting diagnostic workups that require functional and molecular-level imaging. Delivered through Medcare's imaging centres.
- Integrated Diagnostics Ecosystem (Imaging + Genomics) A unified diagnostics platform combining advanced imaging with genomic and multi-omics testing for oncology and complex disease management. Brings together imaging, pathology, and genomics services following the MedGenome–Medcare integration.
Companies that use Medcare Diagnostics
Customer profileSegments1 record
Ideal customer profiles1 record
Medcare Diagnostics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Medcare Diagnostics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- 50+ Hospital PartnerscoreMedcare operates a network of over 50 hospital partnerships through which diagnostic imaging services are delivered. These partnerships enable referrals and integrated diagnostic services across the hospital network in western India.
Scale indicators3 records
Recent moves5 records
Expansion highlights4 records
Medcare Diagnostics competitors and assessment
Company assessmentBroad incumbents
- Apollo Diagnostics: Diagnostic arm of Apollo Hospitals offering imaging and pathology services in major Indian cities including Mumbai. Hospital-anchored model competes for Medcare's referral relationships.
- SRL Diagnostics (Agilus Diagnostics): Large national diagnostic network offering imaging and lab services with a footprint that includes Mumbai hospitals. A broad incumbent across multiple modalities including nuclear medicine.
- Thyrocare Technologies: Indian diagnostic chain focused on preventive and routine pathology plus radiology partnerships. Competes in the broader diagnostics ecosystem where Medcare operates.
- Dr. Lal PathLabs: India's largest listed diagnostic network offering imaging, pathology, and preventive health across India. Competes for hospital referral contracts and patient-direct diagnostics in Mumbai with a much broader test menu.
- Metropolis Healthcare: Pan-India diagnostic chain with significant Mumbai presence offering radiology, pathology, and wellness testing. Competes for both outpatient and hospital-partnership imaging volume.
Direct peers
- Suburban Diagnostics: Multi-modality diagnostic chain headquartered in Mumbai operating imaging centres and lab services. Direct competitor for imaging referrals across the same catchment area as Medcare.
Regional players
- Vijaya Diagnostic Centre: India-focused diagnostic chain with strong imaging capabilities including PET-CT and nuclear medicine. Compares to Medcare on modality mix and outpatient imaging positioning.
- NM Medical: Mumbai-based radiology and imaging chain offering CT, MRI, ultrasound, and PET imaging. Closest geographic and modality overlap with Medcare's four imaging centres.
Others
- MedGenome: Genomics and multi-omics diagnostics company that acquired a majority stake in Medcare in March 2026 — now the parent platform; relevant as the strategic acquirer enabling the integrated diagnostics thesis.
Emerging players
- Tata 1mg (1mg): Digital health and diagnostics aggregator in India with growing imaging booking partnerships. Represents an emerging channel and competitive threat in consumer-facing diagnostic access.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks4 records
Key highlights5 records
Customer concentration
Medcare Diagnostics social profiles
Digital presenceMedcare Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medcare Diagnostics leadership team
Management profileNumber of profiles
Medcare Diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medcare Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medcare Diagnostics
What does Medcare Diagnostics do?
Medcare Diagnostics operates four integrated imaging centers across Mumbai (Chembur, Goregaon, Andheri, and Navi Mumbai) providing radiology, nuclear medicine, and PET-CT imaging services. Following MedGenome's majority investment, the offering is being extended into an integrated diagnostics ecosystem combining imaging with genomic and multi-omics testing for oncology and complex disease management.
Is Medcare Diagnostics a public or private company?
Medcare Diagnostics is a private company. It is classified as corporate owned and is currently operating.
When was Medcare Diagnostics founded?
Medcare Diagnostics was founded in 2012. It employs 51 to 100 people.
Where is Medcare Diagnostics based?
Medcare Diagnostics is headquartered in Mumbai, India, in the Asia region.
Who are Medcare Diagnostics's main competitors?
Broad incumbents on record are Apollo Diagnostics, SRL Diagnostics (Agilus Diagnostics), Thyrocare Technologies, Dr. Lal PathLabs and Metropolis Healthcare. Suburban Diagnostics is listed as a direct peer. Regional players are Vijaya Diagnostic Centre and NM Medical. MedGenome is listed as an others. Tata 1mg (1mg) is listed as an emerging player.
Does Medcare Diagnostics have an API?
No public API is recorded for Medcare Diagnostics.
What industry is Medcare Diagnostics in?
Medcare Diagnostics's product category is Diagnostic Imaging Services. Its primary akta.pro industry code is HLAFAKAB, Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology), with a secondary code of HLAIAGAI, Nuclear Medicine Clinical Services & Therapy Centers. Its NAICS code is 621512 and its SIC code is 8011.